080720.KS · 한국유니온제약
South Korea · RS rating 41 · As of 2026-10-14
| Price | 2,410.00 KRW |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 63 / 17 / 52 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 25 / 49 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +117.1% |
| Sales growth Q/Q | +0.7% |
| Distance from 52-week high | +11.6% |
| Market cap (USD) | $53.9M |